Cytokinetics
CYTK
#1825
Rank
โ‚ฌ10.28 B
Marketcap
75,77ย โ‚ฌ
Share price
1.44%
Change (1 day)
167.56%
Change (1 year)

Market capitalization of Cytokinetics (CYTK)

Market cap: โ‚ฌ10.28 Billion

As of July 2026 Cytokinetics has a market cap of โ‚ฌ10.28 Billion. This makes Cytokinetics the world's 1825th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cytokinetics from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ10.28 B56.61%
2025โ‚ฌ6.56 B22.29%
2024โ‚ฌ5.37 B-27.47%
2023โ‚ฌ7.40 B83.2%
2022โ‚ฌ4.04 B19.01%
2021โ‚ฌ3.39 B184.05%
2020โ‚ฌ1.19 B113.37%
2019โ‚ฌ0.56 B85.4%
2018โ‚ฌ0.30 B-17.41%
2017โ‚ฌ0.36 B-21.98%
2016โ‚ฌ0.46 B23.9%
2015โ‚ฌ0.37 B48.72%
2014โ‚ฌ0.25 B76.31%
2013โ‚ฌ0.14 B103.17%
2012โ‚ฌ71.07 M33.03%
2011โ‚ฌ53.43 M-49.18%
2010โ‚ฌ0.10 B-15.53%
2009โ‚ฌ0.12 B22.25%
2008โ‚ฌ0.10 B-36.23%
2007โ‚ฌ0.15 B-34.93%
2006โ‚ฌ0.24 B65.55%
2005โ‚ฌ0.14 B-26.94%
2004โ‚ฌ0.20 B

End of Day market cap according to different sources

On Jul 5th, 2026 the market cap of Cytokinetics was reported to be:

โ‚ฌ9.42 Billion
by Nasdaq info icon info icon
โ‚ฌ10.28 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
โ‚ฌ176.89 B 1,619.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
โ‚ฌ0 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚ฌ5.61 B-45.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
โ‚ฌ0.71 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
โ‚ฌ0.93 B-90.87%๐Ÿ‡บ๐Ÿ‡ธ USA